Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II–angiotensin type 1 receptor system
- 1 November 2006
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 41 (5) , 798-806
- https://doi.org/10.1016/j.yjmcc.2006.07.004
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplantThe Journal of Heart and Lung Transplantation, 2004
- Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in VivoJournal of Biological Chemistry, 2004
- Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart VentriclesCirculation, 2003
- Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac DysfunctionCirculation, 2003
- Tissue Angiotensin II During Progression or Ventricular Hypertrophy to Heart Failure in Hypertensive Rats; Differential Effects on PKCε and PKCβJournal of Molecular and Cellular Cardiology, 2002
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related CarboxypeptidaseJournal of Biological Chemistry, 2002
- Molecular and Functional Characteristics of APJJournal of Biological Chemistry, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998